肝硬化门静脉高压的无创评估：肝脏硬度及其他方面。
Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.
作者信息
Stefanescu Horia, Procopet Bogdan
机构信息
Horia Stefanescu, Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy.
出版信息
World J Gastroenterol. 2014 Dec 7;20(45):16811-9. doi: 10.3748/wjg.v20.i45.16811.
Abstract
Liver stiffness measurement (LSM) is a good, but still limited tool to noninvasively assess complications and prognosis in patients with advanced liver disease. This review aims to consider the role of LSM for the diagnosis of portal hypertension-related complications and for assessment of prognosis in cirrhotic patients, and to highlight the drawbacks as well as some alternatives for improving the performance. Hence, this field is far from being closed, and deserves more attention. There is still a place for more carefully designed studies to find new, innovative and reliable approaches.
摘要
肝脏硬度测量（LSM）是一种用于无创评估晚期肝病患者并发症和预后的良好但仍有局限性的工具。本综述旨在探讨LSM在诊断门静脉高压相关并发症以及评估肝硬化患者预后方面的作用，并强调其缺点以及一些可改善性能的替代方法。因此，该领域远未定论，值得更多关注。仍需要开展更精心设计的研究，以找到新的、创新且可靠的方法。
相似文献
1
Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.肝硬化门静脉高压的无创评估：肝脏硬度及其他方面。
World J Gastroenterol. 2014 Dec 7;20(45):16811-9. doi: 10.3748/wjg.v20.i45.16811.
2
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature.肝硬化患者中评估门静脉高压的肝脏和脾脏硬度及其他非侵入性方法：文献综述
Eur J Gastroenterol Hepatol. 2015 Sep;27(9):992-1001. doi: 10.1097/MEG.0000000000000393.
3
Liver stiffness measurement, better than APRI, Fibroindex, Fib-4, and NBI gastroscopy, predicts portal hypertension in patients with cirrhosis.肝脏硬度测量在预测肝硬化患者门静脉高压方面优于APRI、Fibroindex、Fib-4和窄带成像胃镜检查。
Cell Biochem Biophys. 2015 Mar;71(2):865-73. doi: 10.1007/s12013-014-0275-z.
4
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.测量脾脏硬度评估丙型肝炎相关肝硬化患者的门静脉高压和食管静脉曲张的存在。
Gastroenterology. 2012 Sep;143(3):646-654. doi: 10.1053/j.gastro.2012.05.035. Epub 2012 May 27.
5
Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.血清学检测、肝脏硬度检测和人工神经网络在肝硬化和门静脉高压症诊断中的应用。
Dig Liver Dis. 2015 May;47(5):411-6. doi: 10.1016/j.dld.2015.02.001. Epub 2015 Feb 7.
6
Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond.肝硬化患者门静脉高压的评估：肝静脉压力梯度及其他方面。
Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1153-1164. doi: 10.1080/00365521.2018.1506046. Epub 2018 Oct 21.
7
Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.基线和系列肝脏硬度测量对代偿期肝硬化患者门静脉高压进展的预测作用
Liver Int. 2014 Oct;34(9):1340-8. doi: 10.1111/liv.12525. Epub 2014 Mar 28.
8
Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?瞬时弹性成像在肝硬化门静脉高压诊断中的应用：肝静脉压力梯度测量是否仍有作用？
Hepatology. 2007 May;45(5):1087-90. doi: 10.1002/hep.21731.
9
Clinical Evaluation and Prognosis.临床评估与预后
Dig Dis. 2015;33(4):515-23. doi: 10.1159/000374100. Epub 2015 Jul 6.
10
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.代偿期慢性肝病患者门静脉高压的非侵入性诊断。
Am J Gastroenterol. 2021 Apr;116(4):723-732. doi: 10.14309/ajg.0000000000000994.
引用本文的文献
1
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives.代谢功能障碍相关脂肪性肝病患者的肝脏硬度测量：方法有效性及前景的最新进展
World J Hepatol. 2025 Jul 27;17(7):106675. doi: 10.4254/wjh.v17.i7.106675.
2
Biophysical cues of in vitro biomaterials-based artificial extracellular matrix guide cancer cell plasticity.基于体外生物材料的人工细胞外基质的生物物理线索引导癌细胞可塑性。
Mater Today Bio. 2023 Mar 8;19:100607. doi: 10.1016/j.mtbio.2023.100607. eCollection 2023 Apr.
3
Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease.肝病中基质硬度的调节因子、功能及机械转导途径
Front Physiol. 2023 Jan 12;14:1098129. doi: 10.3389/fphys.2023.1098129. eCollection 2023.
4
RLLB/Alb ratio: a promising noninvasive diagnostic marker in assessing esophageal varices in cirrhotic patients.RLLB/Alb 比值：评估肝硬化患者食管静脉曲张的有前途的非侵入性诊断标志物。
J Clin Lab Anal. 2022 Aug;36(8):e24589. doi: 10.1002/jcla.24589. Epub 2022 Jul 8.
5
Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal Hemorrhage.预测食管静脉曲张出血的非侵入性标志物评估
Front Med (Lausanne). 2021 Dec 1;8:770836. doi: 10.3389/fmed.2021.770836. eCollection 2021.
6
The role of endoscopic ultrasound for portal hypertension in liver cirrhosis.内镜超声在肝硬化门静脉高压症中的作用。
J Med Ultrason (2001). 2022 Jul;49(3):359-370. doi: 10.1007/s10396-021-01165-4. Epub 2021 Nov 19.
7
Evaluation of Non-invasive Fibrosis Markers in Predicting Esophageal Variceal Bleeding.评估非侵入性纤维化标志物对预测食管静脉曲张出血的作用。
Clin Endosc. 2021 Nov;54(6):857-863. doi: 10.5946/ce.2021.028. Epub 2021 May 26.
8
Assessing Baveno VI Criteria Using Liver Stiffness Measured with a 2D-Shear Wave Elastography Technique.使用二维剪切波弹性成像技术测量肝脏硬度来评估巴韦诺VI标准
Diagnostics (Basel). 2021 Apr 21;11(5):737. doi: 10.3390/diagnostics11050737.
9
Diffusion tensor imaging of the spleen in prediction and grading of esophageal varices in cirrhotic children with portal hypertension.脾弥散张量成像在预测和分级肝硬化门静脉高压症儿童食管静脉曲张中的作用。
Jpn J Radiol. 2021 Sep;39(9):907-913. doi: 10.1007/s11604-021-01123-7. Epub 2021 Apr 29.
10
Accurate ultrasonography-based portal pressure assessment in patients with hepatocellular carcinoma.基于超声检查的肝细胞癌患者门静脉压力准确评估
World J Gastrointest Oncol. 2020 Aug 15;12(8):931-941. doi: 10.4251/wjgo.v12.i8.931.
本文引用的文献
1
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.肝硬化的竞争风险和预后分期：一项 25 年的 494 例患者起始队列研究。
Aliment Pharmacol Ther. 2014 May;39(10):1180-93. doi: 10.1111/apt.12721. Epub 2014 Mar 24.
2
Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.基线和系列肝脏硬度测量对代偿期肝硬化患者门静脉高压进展的预测作用
Liver Int. 2014 Oct;34(9):1340-8. doi: 10.1111/liv.12525. Epub 2014 Mar 28.
3
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study.脾脏硬度测量可预测代偿期 HCV 相关肝硬化的临床并发症：一项前瞻性研究。
J Hepatol. 2014 Jun;60(6):1158-64. doi: 10.1016/j.jhep.2014.02.024. Epub 2014 Mar 6.
4
Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.肝纤维化无创性检测的演变与慢性丙型肝炎患者的预后相关。
Hepatology. 2014 Jul;60(1):65-76. doi: 10.1002/hep.27069.
5
Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.瞬时弹性成像测量的肝硬度的基线值和变化与原发性硬化性胆管炎患者纤维化的严重程度和结局相关。
Gastroenterology. 2014 Apr;146(4):970-9; quiz e15-6. doi: 10.1053/j.gastro.2013.12.030. Epub 2013 Dec 31.
6
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis.瞬时弹性成像技术测量改良脾脏硬度与代偿期丙型肝炎病毒肝硬化患者存在大的食管静脉曲张相关。
J Viral Hepat. 2013 Dec;20(12):867-74. doi: 10.1111/jvh.12114. Epub 2013 Aug 12.
7
Accuracy of spleen stiffness measurement in detection of esophageal varices in patients with chronic liver disease: systematic review and meta-analysis.脾脏硬度测量在慢性肝病患者食管静脉曲张检测中的准确性：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2014 Jun;12(6):935-45.e4. doi: 10.1016/j.cgh.2013.09.013. Epub 2013 Sep 18.
8
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.肝脏硬度与慢性肝病患者的失代偿、肝癌和死亡风险相关：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1573-84.e1-2; quiz e88-9. doi: 10.1016/j.cgh.2013.07.034. Epub 2013 Aug 15.
9
10
Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension.进食对肝硬化和门静脉高压患者肝硬度的影响。
PLoS One. 2013;8(3):e58742. doi: 10.1371/journal.pone.0058742. Epub 2013 Mar 8.
Zotero 插件